The following articles discuss possible treatment options for Actinobaculum schaalii.
[1] [2] [3] [4] [5]References
- R. Lotte, L. Lotte, and R. Ruimy, "Actinotignum schaalii (formerly Actinobaculum schaalii ): a newly recognized pathogen—review of the literature", Clinical Microbiology and Infection, vol. 22, pp. 28-36, 2016. http://dx.doi.org/10.1016/j.cmi.2015.10.038
- H. Pedersen, E. Senneby, and M. Rasmussen, "Clinical and microbiological features of Actinotignum bacteremia: a retrospective observational study of 57 cases", European Journal of Clinical Microbiology & Infectious Diseases, vol. 36, pp. 791-796, 2016. http://dx.doi.org/10.1007/s10096-016-2862-y
- V. Cattoir, A. Varca, G. Greub, G. Prod'hom, P. Legrand, and R. Lienhard, "In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance", Journal of Antimicrobial Chemotherapy, vol. 65, pp. 2514-2517, 2010. http://dx.doi.org/10.1093/jac/dkq383
- G. Prigent, C. Perillaud, M. Amara, A. Coutard, C. Blanc, and B. Pangon, "Actinobaculum schaalii: A truly emerging pathogen?", New Microbes and New Infections, vol. 11, pp. 8-16, 2016. http://dx.doi.org/10.1016/j.nmni.2015.10.012
- V. Cattoir, "Actinobaculum schaalii: Review of an emerging uropathogen", Journal of Infection, vol. 64, pp. 260-267, 2012. http://dx.doi.org/10.1016/j.jinf.2011.12.009